Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy, Adjuvant”

1,326 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,326 results

Testing effectiveness (Phase 2)Study completedNCT01440270
What this trial is testing

Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer

Who this might be right for
Locally Advanced Malignant NeoplasmOral CancerOropharyngeal Carcinoma
Shanghai Jiao Tong University School of Medicine 145
Large-scale testing (Phase 3)UnknownNCT01534546
What this trial is testing

Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection

Who this might be right for
Advanced Gastric Carcinoma
Peking University 1,094
Early research (Phase 1)Ended earlyNCT03956056
What this trial is testing

Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Who this might be right for
Pancreas CancerPancreatic CancerCancer of the Pancreas
Washington University School of Medicine 12
Large-scale testing (Phase 3)Study completedNCT00014222
What this trial is testing

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 2,104
Testing effectiveness (Phase 2)Study completedNCT00052351
What this trial is testing

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Not applicableEnded earlyNCT02050737
What this trial is testing

Plasma Biomarkers C-RAC, ICORG 12-27, V1

Who this might be right for
Colorectal Cancer
Cancer Trials Ireland 109
Testing effectiveness (Phase 2)Ended earlyNCT00612677
What this trial is testing

Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 1
Testing effectiveness (Phase 2)UnknownNCT04918628
What this trial is testing

Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer

Who this might be right for
Cervical Cancer
Taizhou Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00340184
What this trial is testing

A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients

Who this might be right for
Cervical Cancer
Korean Gynecologic Oncology Group 55
Large-scale testing (Phase 3)Looking for participantsNCT05879926
What this trial is testing

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Who this might be right for
Breast Cancer
NRG Oncology 3,960
Not applicableUnknownNCT01343264
What this trial is testing

Trimodality Therapy for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
HSK Wiesbaden 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03756298
What this trial is testing

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
National Cancer Center, Korea 284
Large-scale testing (Phase 3)Active Not RecruitingNCT01906814
What this trial is testing

Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation

Who this might be right for
Retinoblastoma
Sun Yat-sen University 179
Not applicableStudy completedNCT00562458
What this trial is testing

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
AstraZeneca 200
Large-scale testing (Phase 3)Active Not RecruitingNCT04065009
What this trial is testing

The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer

Who this might be right for
Advanced Ovarian Cancer
Karolinska Institutet 220
Large-scale testing (Phase 3)Looking for participantsNCT04453826
What this trial is testing

Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CancerChemotherapyRadiotherapy+1 more
Sun Yat-sen University 388
Testing effectiveness (Phase 2)UnknownNCT01168505
What this trial is testing

Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients

Who this might be right for
Breast Cancer
Instituto do Cancer do Estado de São Paulo 100
Not applicableUnknownNCT04789187
What this trial is testing

Exercise, Cancer and Cognition: The ECCO-Study

Who this might be right for
Breast Cancer
Johannes Kepler University of Linz 126
Large-scale testing (Phase 3)Study completedNCT01583426
What this trial is testing

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)

Who this might be right for
Tubular Breast Cancer Stage IIMucinous Breast Cancer Stage IIBreast Cancer Female NOS+5 more
GBG Forschungs GmbH 1,229
Large-scale testing (Phase 3)Study completedNCT00431080
What this trial is testing

Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 478
Load More Results